Medication info
Cozaar 100 mg (Losartan Potassium)

Cozaar 100 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›100mg / 1 tablet
Manufacturer / importer
Organon Korea Co., Ltd.
Appearance
White drop-shaped film-coated tablets imprinted with 960 on one side
Packaging
30 tablets (10 tablets/PTP x 3), 300 tablets (300 tablets/bottle)
Approval status
Active

MFDS item code 200810031 · Approved 2008.09.30 · Insurance code 073100250

Summary

Main use
Treatment of hypertension, prevention of stroke in patients with left ventricular hypertrophy, and treatment of kidney disease in type 2 diabetes
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension, adults: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, the dose may be increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. Reduction of the risk of stroke in hypertensive patients with left ventricular hypertrophy: The usual initial dose in adults is 50 mg of this medicine once daily. Depending on blood pressure, hydrochlorothiazide 12.5 mg once daily may be added and/or the dose of this medicine may be increased to 100 mg once daily. If additional blood pressure reduction is needed, hydrochlorothiazide may be increased to 25 mg once daily. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No initial dose adjustment is necessary in patients aged 75 years or younger. For patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have intravascular volume depletion (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Pediatric and adolescent patients aged 6 years and older, weighing 20 kg or more and less than 50 kg, who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50 mg once daily depending on the patient's blood pressure response. Pediatric and adolescent patients aged 6 years and older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Importer
Organon Korea Co., Ltd.

Efficacy & effects

Treatment of hypertension, prevention of stroke in patients with left ventricular hypertrophy, and treatment of kidney disease in type 2 diabetes

  • Hypertension
  • left ventricular hypertrophy
  • risk of stroke
  • kidney disease
View approved original text

This medication helps lower blood pressure in patients with hypertension and reduces the risk of stroke associated with left ventricular hypertrophy. It is also used to slow the progression of kidney disease in patients with hypertension and type 2 diabetes. Therefore, it is effectively used in the prevention and treatment of various complications associated with hypertension.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension, adults: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, the dose may be increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. Reduction of the risk of stroke in hypertensive patients with left ventricular hypertrophy: The usual initial dose in adults is 50 mg of this medicine once daily. Depending on blood pressure, hydrochlorothiazide 12.5 mg once daily may be added and/or the dose of this medicine may be increased to 100 mg once daily. If additional blood pressure reduction is needed, hydrochlorothiazide may be increased to 25 mg once daily. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No initial dose adjustment is necessary in patients aged 75 years or younger. For patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have intravascular volume depletion (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Pediatric and adolescent patients aged 6 years and older, weighing 20 kg or more and less than 50 kg, who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50 mg once daily depending on the patient's blood pressure response. Pediatric and adolescent patients aged 6 years and older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Women of childbearing potential should not take this medication, especially during the second and third trimesters of pregnancy, as it is particularly dangerous. This medication should not be administered to patients with certain allergic reactions, severe liver dysfunction, or a history of angioedema. Caution is needed when using this medication in elderly patients, those with impaired kidney function, or patients with hyperkalemia. Regular monitoring of blood pressure, kidney function, and electrolyte levels is essential during treatment, and consultation with medical personnel is necessary if any unusual symptoms appear. Particularly, watch for symptoms of sudden hypotension or increased potassium levels in the blood. This medication may have an increased risk of side effects when used in conjunction with certain other medications, so patients should inform their healthcare provider of any other medications they are taking. The use of potassium supplements or potassium-containing medications is not recommended. Caution is especially important in patients with liver or kidney diseases, as this medication can affect these organs. Dizziness or drowsiness may occur, requiring caution when driving or operating machinery. It is safer for children or those with severely impaired kidney function not to use this medication. In case of overdose, symptoms such as hypotension and arrhythmia may occur, necessitating immediate medical attention. This medication should be stored out of the reach of children, and transferring to another container should be avoided.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • muscle cramps
  • back pain
  • leg pain
  • dizziness
  • congestion
  • upper respiratory infection
Show 131 more
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • bloating
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm skin peeling
  • hemolysis
  • facial swelling
  • fever
  • orthostatic effects
  • syncope
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle stiffness
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorders
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • decreased libido
  • memory impairment
  • migraine
  • neuroasthenia
  • sensory disturbances
  • peripheral neuropathy
  • panic disorder
  • sleep disorders
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • thoracic discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reaction
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning and pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • decreased vision
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urinary tract infection
  • vascular swelling
  • vasculitis
  • anaphylactic syndrome
  • liver dysfunction
  • hepatitis
  • malaise
  • thrombocytopenia
  • myalgia
  • weakness
  • elevated creatine kinase
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • increased BUN
  • increased serum creatinine
  • decreased hemoglobin
  • decreased hematocrit
  • elevated liver enzymes
  • increased serum bilirubin
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beats
  • hypoglycemia
  • recurrent cough

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White drop-shaped film-coated tablets imprinted with 960 on one side

Package unit

30 tablets (10 tablets/PTP x 3), 300 tablets (300 tablets/bottle)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.